Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)
ClinicalTrials.gov study NCT00891462. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms
ClinicalTrials.gov study NCT00565136. IPD Sharing: NO. Countries: 1. Publications: 1.
Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma
ClinicalTrials.gov study NCT00679263. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03410992. IPD Sharing: NO. Countries: 9. Publications: 7.
Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines
ClinicalTrials.gov study NCT00856414. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
ClinicalTrials.gov study NCT00857649. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease
ClinicalTrials.gov study NCT01696396. IPD Sharing: Not stated. Countries: 12. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)
ClinicalTrials.gov study NCT04417894. IPD Sharing: YES. Countries: 4. Publications: 1.
Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity
ClinicalTrials.gov study NCT03746522. IPD Sharing: NO. Countries: 6. Publications: 4.
Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis
ClinicalTrials.gov study NCT02296775. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease
ClinicalTrials.gov study NCT00710684. IPD Sharing: Not stated. Countries: 9. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03370133. IPD Sharing: NO. Countries: 11. Publications: 10.
Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic
ClinicalTrials.gov study NCT02296138. IPD Sharing: Not stated. Countries: 51. Publications: 4.
Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chron
ClinicalTrials.gov study NCT03162055. IPD Sharing: UNDECIDED. Countries: 7. Publications: 1.
A Phase 2a Safety and Efficacy Open-Label Study of PRA023 in Subjects With Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT05013905. IPD Sharing: YES. Countries: 8. Publications: 1.
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
ClinicalTrials.gov study NCT00658528. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis
ClinicalTrials.gov study NCT04360187. IPD Sharing: YES. Countries: 3. Publications: 1.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension
ClinicalTrials.gov study NCT04936035. IPD Sharing: YES. Countries: 5. Publications: 1.
Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects
ClinicalTrials.gov study NCT01708590. IPD Sharing: YES. Countries: 6. Publications: 1.
Light Therapy for Moderate Traumatic Brain Injury
ClinicalTrials.gov study NCT02233413. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.